Case Report

Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab

Table 1

Patient laboratory value after initiation of immunotherapy with nivolumab.

ParameterNivolumab therapyNivolumab withdrawal
Day 0Day 105Day 130AdmissionDischargeMonth 1Month 2Month 6

Serum creatinine (μmol/L)79.56176.8362.4433.1433.2274.1194.5159.1

(ml/min/1.73m2)92.535,214,811.914.820.731.440

Serum sodium (mmol/L)-145-138143137140143

Serum potassium (mmol/L)-5.3-5.84.35.44.54.7

Serum calcium (mmol/L)-2.45-2.22.22.42.22.25

Serum phosphate (mmol/L)---1.351.321.420.971.23

Eosinophil count (cells/μL, %)--320 (6.9%)260 (4.0%)230 (3.7%)80 (0.9%)50, (0.5%)

CRP (nmol/L)---780.0207.6138.185.757.1

UPE (mg/day)---180-190201266

CRP= C-reactive protein; eGFR= estimated glomerular filtration rate; UPE= urine protein excretion.
-EPI equation was used to estimate eGFR